Global Value Chains: Where They Came From, Where They Are Going and Why This Is Important
Raphael Kaplinsky
November 2013
Shudder: The Challenges to 'Industrial Policies' in the Early 21st Century in Low- and Middle-Income Economies
Raphael Kaplinsky
July 2013
The Public-Private Interface in Public Services Reforms: Analysis and Illustrative Evidence from the Tanzanian Health Sector
Paula Tibandebage, Maureen Mackintosh and Tausi Kida
April 2013
Inclusive Innovation: An Architecture for Policy Development
Joanna Chataway, Rebecca Hanlin and Raphael Kaplinsky
March 2013
Understanding Rural Co-operative Resilience: A Literature Review
Alexander Borda-Rodriguez and Sara Vicari
February 2013
Innovation and Development in Search of a Political Theory of Justice
Theo Papaioannou
November 2012
'Bottom of the Pyramid Innovation' and Pro-Poor Growth
Raphael Kaplinsky
November 2011
Knowledge in Development Aid and Healthcare: A Comparative Analysis
Alex Borda-Rodriguez
October 2011
Sources of Innovation and Technology Capability Development in the Indian Automobile Industry
Dinar Kale
October 2011
The Determinants of Upgrading and Value Added in the African Clothing Sector: The Contrasting Experiences of Kenya and Madagascar
Raphael Kaplinsky, Watu Wamae
October 2010
New Drugs and Health Technologies for Low-Income Populations: Will the Private Sector Meet the Needs of Low-Income Populations in Developing Countries?
Joanna Chataway, Dinar Kale, Rebecca Hanlin
October 2010
The role of standards in global value chains
Raphael Kaplinsky
June 2010
What Happens When the Market Shifts to China? The Gabon Timber and Thai Cassava Value Chains
Raphael Kaplinsky, Anne Terheggen, Julia Tijaja
February 2010
What are the Implications for Global Value Chains When the Market Shifts from the North to the South?
Raphael Kaplinsky, Masuma Farooki
February 2010
Schumacher Meets Schumpeter: Appropriate Technology below the Radar
Raphael Kaplinsky
December 2009
Innovation in Venture-Capital Backed Clean-Technology Firms in the UK
Stuart Parris and Pelin Demirel
February 2010
Does the Economic Recession Create Opportunities for Wealth Taxation?
Rajiv Prabhakar
February 2010
US Biopharmaceutical Finance and the Sustainability of the Biotech Boom
William Lazonick and Öner Tulum
July 2009
The Impact of China's Exports on Global Manufactures Prices
Xiaolan Fu, Raphael Kaplinsky and Jing Zhang
October 2009
The Evolution of Global Manufactures Prices 1988-2006: China's Comparative Performance
Xiaolan Fu, Dinar Kale and Raphael Kaplinsky
September 2009
Venture Capital Networks in the UK: National or Regional?
Stuart Parris
August 2009
Common Health Policy Interests between North and South in Pharmaceutical Policy and Global Public Policies
Meri Koivusalo
May 2009
Non-Government Intervention and Prices of Medicines in India: Case Studies of CDMU and LOCOST
Global Public Action in Health and Pharmaceutical Policies: Politics and Policy Priorities
Meri Koivusalo and Maureen Mackintosh
February 2009
Global Justice: From Theory to Development Action
Theo Papaioannou, Helen Yanakopoulos and Zuhre Aksoy
February 2009
Bio-clusters as Co-evolutionary Developments of High Tech, Venture Capital and Socio-Political Institutions: A Historical Perspective of Cambridge and Scotland
Theo Papaioannou and Alessandro Rosiello
February 2009
Public-Private Collaboration for New Life Sciences Innovation and Regional Development: the Cases of Cambridge and Scotland
Theo Papaioannou
February 2009
Below the Radar: What Does Innovation in the Asian Driver Economies Have to Offer Other Low-Income Economies?
Corresponding author: Norman Clark
January 2009
Consumer Rights and Non-Governmental Action in Medicines Markets: Knowledge, Risk and Trust in Rural Tanzania
Phares G M Mujinja
October 2008
The Evolution of Firm Growth Dynamics in the US Pharmaceutical Industry: Is ‘Structure’ in the Growth Process Related to Size and Location Dynamics?
Mariana Mazzucato, and Pelin Demirel
September 2008
Indian Generic Companies, Affordability of Drugs and Local Production in Africa with Special Reference to Tanzania
Sudip Chaudhuri
September 2008
Boston’s Biotech Boom: A 'New Massachusetts Miracle'
William Lazonick, Edward March and Öner Tulum
September 2008
Entrepreneurial Ventures and the Developmental State: Lessons from the Advanced Economies
William Lazonick
September 2008
Innovation, Poverty and Inequality: Cause or Coincidence? A Synoptic Overview
Raphael Kaplinsky
July 2008
Does Market Selection Reward Innovators? R&D, Patents, and Growth in the US Pharmaceutical Industry
Pelin Demirel and Mariana Mazzucato
July 2008
Pricing and Competition in Essential Medicines Markets: the Supply Chain to Tanzania and the Role of NGOs
Maureen Mackintosh and Phares G M Mujinja
July 2008
Beyond Benefit-Sharing Agreements: Bioprospecting for the Poor?
Maria-Costanza Torri
April 2008
Social Enterprise as Market Regulation: Non-Governmental Interventions in Essential Medicines Wholesaling to Low-Income Countries
Maureen Mackintosh
March 2008
Biotechnology and Biodiversity Debates and Policies in Africa
Seife Ayele
March 2008
Sustainable Development as Ecological Modernisation: Explaining EU Policy Conflicts over Agbiotech
Les Levidow and David Toke
March 2008
A Critial Assessment of Regional Innovation Policy in Pharmaceutical Biotechnology
Dr Alessandro Rosiello, Prof Luigi Orsenigo
February 2008
The International Aids Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public Private Partnership as Knowledge Broker and Integrator
Joanna Chataway, Stefano Brusoni, Eugenia Cacciatori, Rebecca Hanlin and Luigi Orsenigo
February 2008
Vertical Integration and Dis-integration of Computer Firms: A History Friendly Model of the Co-evolution of the Computer and Semiconductor Industries
Franco Malerba, Richard Nelson, Luigi Orsenigo and Sidney Winter
January 2008
Public Policies and Changing Boundaries of Firms in a 'History Friendly' Model of the Co-Evolution of the Computer and Semiconductor Industries
Franco Malerba, Richard Nelson, Luigi Orsenigo and Sidney Winter
November 2006
Internationalisation Strategies of Indian Pharmaceutical firms
Dinar Kale
December 2007
Public-Private Collaboration in Genomics and Biotechnology: the Cases of Cambridge and Scotland
Theo Papaioannou
September 2007
Planning and Market Regulation: Strengths, Weaknesses and Interactions in the Provision of Less Inequitable and Better Quality Health Care
Maureen Mackintosh
October 2007 (Revised April 2008)
Stock Price Volatility and Patent Citation Dynamics: the case of the pharmaceutical industry
Mariana Mazzucato and Massimiliano Tancioni
December 2006
The Grey Entrepreneurs in UK
Suresh H Patel and Colin Gray
November 2006
Diffusion of Knowledge through Migration of Scientific Labour in India
Dinar Kale, David Wield, Joanna Chataway
November 2006
Experimentation with Strategy in the Indian Pharmaceutical Sector
Suma Athreye and Dinar Kale
November 2006
GMO Governance in Africa
Seife Ayele
November 2006
Does International Trade Transfer Technology to Emerging Countries? A Patent Citation Analysis
Elif Bascavusoglu
September 2005
Innovation Dynamics in Follower Firms: Process, Product and Proprietary Technology for Development
Naushad Forbes and David Wield
March 2006
Knowledge, Innovation and Re-inventing Technical Assistance for Development
Gordon Wilson
April 2006
Exploitative and Explorative Learning as a Response to the TRIPS Agreement in Indian Pharmaceutical Firms: Some Implications for Other Developing Countries
Dinar Kale and David Wield
March 2006
e-Governance Issues in SME Networks
Colin Gray
March 2006
The Governance of Genomics Science and Technology : Prospects for Development?
Adèle Langlois, May 2005
Development Policy and Practice Policy and Technology Co-evolution in the Indian Pharmaceutical Industry
Kalpana Chaturvedi
December 2005
Innovation and Idiosyncratic Risk: An Industry and Firm Level Analysis
Mariana Mazzucato and Massimiliano Tancioni
July 2008
SAAVI Case Study and The 3 'C's (Collaboration, Capacity and Capabilities) : Linking Innovation Systems and Health Systems in Development
Rebecca Hanlin
January 2006
Smoke, Mirrors and Poverty: Communication, Biotechnological Innovation and Development
Joanna Chataway and James Smith
September 2005
The Regulation of Agricultural Biotechnology in Poland and the Obstacles to EU Compliance
Farah Huzair
January 2006
Creating Competition? Globalisation and the Emergence of New Technology Producers
Suma Athreye and John Cantwell
October 2005
Partnerships and Building Capabilities for Science, Technology, Innovation and Development in Africa
Joanna Chataway, James Smith and David Wield
November 2005
Age Effects on Small Firm Growth and Strategic Objectives
Colin Gray
November 2005